MMS Stock Summary and Trading Ideas (Maximus | NYSE:MMS)

Maximus Inc is an operator of government health and human services programs in the United States, United Kingdom, Canada, Australia, and Saudi Arabia. The company offers business solutions to improve the cost-effectiveness, efficiency, and quality of government-sponsored benefit programs, such as Medicaid, Medicare, Health Insurance BC, and child support programmes. Most of its revenue is derived from long-term contractual arrangements with governments around the world. The company generates maximum revenue from the U.S. Federal Services segment.

Maximus trades on the NYSE stock market under the symbol MMS.

As of April 18, 2024, MMS stock price climbed to $80.04 with 270,931 million shares trading.

MMS has a beta of 1.13, meaning it tends to be more sensitive to market movements. MMS has a correlation of 0.35 to the broad based SPY ETF.

MMS has a market cap of $4.88 billion. This is considered a Mid Cap stock.

Last quarter Maximus reported $1 billion in Revenue and $1.34 earnings per share. This beat revenue expectation by $37 million and exceeded earnings estimates by $.33.

In the last 3 years, MMS stock traded as high as $96.05 and as low as $54.46.

The top ETF exchange traded funds that MMS belongs to (by Net Assets): VTI, IJH, VB, IWM, VXF.

MMS has underperformed the market in the last year with a return of -3.4%, while the SPY ETF gained +22.3%. In the last 3 month period, MMS fell short of the market, returning -0.6%, while SPY returned +6.1%. However, in the most recent 2 weeks MMS has outperformed the stock market by returning -1.1%, while SPY returned -3.8%.

MMS support price is $78.73 and resistance is $80.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MMS stock will trade within this expected range on the day.